Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚ฌ3.12 B
Marketcap
158,78ย โ‚ฌ
Share price
-1.93%
Change (1 day)
34.39%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.58 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has โ‚ฌ0.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ligand Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.24 B59.78%
2023-12-31โ‚ฌ0.15 B-22%
2022-12-31โ‚ฌ0.19 B-34.42%
2021-12-31โ‚ฌ0.30 B-9.9%
2020-12-31โ‚ฌ0.33 B-65%
2019-12-31โ‚ฌ0.95 B41.19%
2018-12-31โ‚ฌ0.67 B302.46%
2017-12-31โ‚ฌ0.16 B25.34%
2016-12-31โ‚ฌ0.13 B-26.77%
2015-12-31โ‚ฌ0.18 B33.09%
2014-12-31โ‚ฌ0.13 B1089.13%
2013-12-31โ‚ฌ11.57 M23.62%
2012-12-31โ‚ฌ9.35 M-28.67%
2011-12-31โ‚ฌ13.12 M-23.1%
2010-12-31โ‚ฌ17.06 M-54.07%
2009-12-31โ‚ฌ37.15 M-35.61%
2008-12-31โ‚ฌ57.7 M-10.75%
2007-12-31โ‚ฌ64.65 M-50.35%
2006-12-31โ‚ฌ0.13 B77.47%
2005-12-31โ‚ฌ73.38 M-11.51%
2004-12-31โ‚ฌ82.92 M5.42%
2003-12-31โ‚ฌ78.66 M27.99%
2002-12-31โ‚ฌ61.46 M44.02%
2001-12-31โ‚ฌ42.67 M69.89%
2000-12-31โ‚ฌ25.11 M-46.45%
1999-12-31โ‚ฌ46.9 M69.7%
1998-12-31โ‚ฌ27.64 M-47.35%
1997-12-31โ‚ฌ52.49 M79.02%
1996-12-31โ‚ฌ29.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
โ‚ฌ8.11 B 1,295.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ48.21 M-91.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ3.81 B 556.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ15.64 B 2,590.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 2,113.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ8.51 B 1,364.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 2,337.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ1.48 B 154.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ15.94 B 2,642.05%๐Ÿ‡บ๐Ÿ‡ธ USA